Description
Colivelin research peptide
Colivelin is a synthetic hybrid peptide that combines activity-dependent neurotrophic factor (ADNF) with a potent humanin analogue.
Product details
| Compound | Colivelin |
|---|---|
| Class | Hybrid neuroprotective peptide (ADNF + humanin analogue) |
| Strength | 100mg; 50mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- Neuroprotection models.
- STAT3 signalling research.
- Humanin analogue research.
Research interest does not establish a proven effect in humans.
Regulatory status
This compound is not an approved medicine. It is supplied only as a research chemical for laboratory use.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Tesamorelin · Oxytocin · Semax · All peptides
References
- PubMed: research reference
- PubMed: research reference (2)
- PubMed: research reference (3)
- NCBI: research reference
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.